Learning from the failures of drug discovery in B-cell non-Hodgkin lymphomas and perspectives for the future: chronic lymphocytic leukemia and diffuse large B-cell lymphoma as two ends of a spectrum in drug development.
about
Learning from the failures of drug discovery in B-cell non-Hodgkin lymphomas and perspectives for the future: chronic lymphocytic leukemia and diffuse large B-cell lymphoma as two ends of a spectrum in drug development.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Learning from the failures of ...... spectrum in drug development.
@en
type
label
Learning from the failures of ...... spectrum in drug development.
@en
prefLabel
Learning from the failures of ...... spectrum in drug development.
@en
P2860
P1476
Learning from the failures of ...... spectrum in drug development.
@en
P2093
Boris Kubuschok
Martin Trepel
P2860
P304
P356
10.1080/17460441.2017.1329293
P407
P577
2017-05-12T00:00:00Z